ANI Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ANIP Nasdaq 2830 www.anipharmaceuticals.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ANI Pharmaceuticals, Inc.

2 Reasons to Like ANIP (and 1 Not So Much) - Aug 27th, 2026 5:45 pm
1 Russell 2000 Stock to Target This Week and 2 We Brush Off - Aug 24th, 2026 9:13 am
ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors - Aug 24th, 2026 4:55 am
The Top 5 Analyst Questions From ANI Pharmaceuticals’s Q2 Earnings Call - Aug 16th, 2026 3:09 am
Winners And Losers Of Q2: ANI Pharmaceuticals (NASDAQ:ANIP) Vs The Rest Of The Generic Pharmaceuticals Stocks - Aug 15th, 2026 11:49 am
Should You Buy ANIP as Low Valuation Meets Cortrophin Execution Risk? - Aug 14th, 2026 11:15 am
ANIP's Cortrophin Guidance Cut Raises the Bar for Second-Half Growth - Aug 14th, 2026 11:12 am
ANI Pharmaceuticals (ANIP) Q2 2026 Earnings Call Transcript - Aug 14th, 2026 7:14 am
ANIP Q2 Deep Dive: Rare Disease Expansion Drives Growth Amid Guidance Recalibration - Aug 11th, 2026 7:33 am
ANIP Tops Q2 Earnings, Stock Down on Cortrophin Sales View Cut - Aug 10th, 2026 11:05 am
ANI Pharmaceuticals (ANIP) Could Be 31% Undervalued On Strong Q2 Results And Guidance Reset - Aug 8th, 2026 1:09 pm
ANI Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Aug 7th, 2026 3:22 pm
ANI Pharmaceuticals Inc (ANIP) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic ... - Aug 7th, 2026 1:01 pm
ANI Pharmaceuticals Q2 Earnings Call Highlights - Aug 7th, 2026 8:04 am
ANI Pharmaceuticals Shares Slide Despite Earnings Beat After Cortrophin Outlook Cut - Aug 7th, 2026 7:59 am
Compared to Estimates, ANI (ANIP) Q2 Earnings: A Look at Key Metrics - Aug 7th, 2026 7:30 am
ANI Pharmaceuticals (ANIP) Q2 Earnings and Revenues Beat Estimates - Aug 7th, 2026 6:05 am
ANI Pharmaceuticals’s (NASDAQ:ANIP) Q2 CY2026 Sales Beat Estimates But Stock Drops On Weak Guidance - Aug 7th, 2026 5:12 am
ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results - Aug 7th, 2026 4:50 am